The Panic-Proof Portfolio (Stockchase Research)
OrganiGram Holdings Inc.
OGI-T
PAST TOP PICK
Feb 09, 2021
(A Top Pick Jan 14/21, Up 57.6%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with OGI has achieved its $3.50 target. To be disciplined, we recommend covering 50% and trailing up the stop (from $1.40) to $2.25 (near the original buy recommendation).
Stockchase Research Editor: Michael O'Reilly OGI is a cannabis producer serving the Canadian market. Recent earnings disappointed on the revenue side (down by 23%), but management is noting that adult recreational use is up 30% over the year. The company is now producing positive cash flows (in 2 of the last 3 quarters), building its cash position, and is successfully paying off debt. We would buy this with a stop-loss at $1.40, looking to achieve $3.50 -- upside potential of 55%. Yield 0% (Analysts’ price target is $3.43)
(A Top Pick Jan 14/21, Up 88.7%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with OGI is progressing well. We recommend trailing up the stop (from $2.25) to $4.00. This would all but guarantee a minimum return on investment of 68%, including the previous recommendation to cover 50% of the position.
It's junk. The CEO just stepped down without a successor. His big beef is that OGI has roots in medical cannabis, but they're early days expanding into recreational weed, which offers more profits. Also, OGI is not expanding into the far-bigger American market. There's no shortage of ways to invest in cannabis. He has a better pick in this industry.
(A Top Pick Jan 14/21, Up 49%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with OGI is progressing well. We recommend trailing the stop to $3. Along with the previous recommendation to cover half the position, this would all but guarantee a net investment return of 46% if triggered.
(A Top Pick Jan 14/21, Up 35.1%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with OGI has triggered its stop at $3.00. We recommend covering the balance of the position at this time. When combined with the previous recommendation to cover half the position, this results in a net investment gain over 46%.